Search Results

Sylvester Comprehensive Cancer Center, University of Miami Scott M. Welford, PhD, is the new Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. He will lead the program with Wael El-Rifai, MD, PhD. Read More

Duke Cancer Institute, Duke University Medical Center Trudy G. Oliver, PhD, has joined the Department of Pharmacology and Cancer Biology. She was recruited from Huntsman Cancer Institute through the Duke Science & Technology initiative in partnership with Duke Cancer Institute. Her research focuses on subtypes of lung cancer, specifically squamous and small cell lung cancer. Read More

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center has tapped three accomplished health care executives to oversee key clinical and operational areas. Ronald Andro, MS, BSN, was promoted to chief clinical operations officer, Catherine Cowan, RN, MSN, has joined Roswell Park as vice president of payer relations, and John Kuhns has been appointed as senior executive director of ambulatory services. Read More

Winship Cancer Institute of Emory University Reshma Jagsi, MD, DPhil, will join Emory School of Medicine and Winship Cancer Institute of Emory University as chair of the Department of Radiation Oncology, effective November 7. Read More

Montefiore Einstein Comprehensive Cancer Center The American Cancer Society (ACS) has awarded Montefiore Einstein Cancer Center more than $2.1 million to support cancer research and reduce individual and systematic barriers that prevent people from accessing cancer care. Read More

UMMC Cancer Center and Research Institute When Pierre de Delva, MD, director of thoracic oncology and program director of thoracic surgery residency, flew to Chicago to accept a Lung Cancer Hero award, he was honored and humbled, but said he didn’t act alone. Read More

Simmons Comprehensive Cancer Center, UT Southwestern Medical Center A set of interacting molecules in immune cells of the gut is responsible for preventing the inflammation seen in inflammatory bowel diseases (IBD), UT Southwestern researchers report in a new study. The findings suggest a new drug target for treating IBD and related conditions. Read More

Fox Chase Cancer Center, Temple Health In a recent study, researchers at Fox Chase Cancer Center demonstrated how cancer cells can survive in the body even when faced with a lack of sufficient nutrition, a finding that could be used as a potential indicator of disease status in the organs of pancreatic cancer patients. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University It may soon be possible to identify Group 4 medulloblastomas from more aggressive Group 3 tumors. Research based on a little-explored part of RNA, which creates proteins, could lead to the development of better-targeted cancer treating drugs, according to investigators at the Johns Hopkins Kimmel Cancer Center. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Researchers at Baylor College of Medicine and collaborating institutions have engineered immune cells to control two major life-threatening complications, namely graft-versus-host disease and cancer relapse, which typically emerge after treating leukemia with allogeneic hematopoietic stem cell transplantation. Read More

Cedars-Sinai Cancer James Turkson, PhD, professor in the Division of Medical Oncology in the Department of Medicine at Cedars-Sinai, is uniquely positioned for a new role developed at Cedars-Sinai Cancer: director for Diversity, Inclusion and Strategy. Read More

University of Michigan Rogel Cancer Center Daniel Chang, MD, was named chair of the Department of Radiation Oncology at Michigan Medicine. Dr. Chang will be the third chair in the department’s 38-year history. He replaces Theodore S. Lawrence, MD, PhD, who served as department chair since 1997. Read More

University of Virginia Cancer Center The University of Virginia School of Medicine has recruited Mariano A. Garcia-Blanco, MD, PhD, an internationally recognized expert in virology and RNA biology, to lead its Department of Microbiology, Immunology and Cancer Biology. Dr. Garcia-Blanco joins UVA from the University of Texas Medical Branch. Read More

Hollings Cancer Center, Medical University of South Carolina Gerard Silvestri, MD, and Marvella Ford, PhD, are co-leaders of a $1.2 million grant from The Duke Endowment, with ambitious goals to increase screening rates for five cancers and expand biomarker research trials in South Carolina. Read More

This fall, AACI welcomed new members to its Clinical Research Innovation (CRI) and Government Relations (GR) steering committees. The new members formally assumed their duties during the 2022 AACI/CCAF Annual Meeting. AACI is also seeking nominations for new members to join the Physician Clinical Leadership Initiative (PCLI) Steering Committee. Read More

UCSF Helen Diller Family Comprehensive Cancer Center A new therapy pulls a mutated version of the protein KRAS to the surface of cancer cells, where the drug-KRAS complex acts as an "eat me" flag. Then, an immunotherapy can coax the immune system to effectively eliminate all cells bearing this flag. Read More

Rutgers Cancer Institute of New Jersey Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Matthew Matasar, MD, MS, as chief of blood disorders. In this role, he will oversee the sections of hematologic malignancies; transplant and cell therapy; and benign hematology. Read More

AACI’s first in-person annual meeting since 2019 attracted over 400 participants, including leaders from 91 cancer centers, for three-and-a-half days of networking, presentations, and panel discussions in Kansas City. Program topics ranged from the Cancer Moonshot and National Cancer Institute funding, to cancer center leadership development, the future of the oncology workforce, clinical trial operations, drug development, and breakthrough research at basic science centers. Read More

UK Markey Cancer Center In a recent UK Markey Cancer Center clinical trial, patients with advanced cancer experienced improved outcomes when their treatments were directed by a molecular tumor board. Read More

USC Norris Comprehensive Cancer Center Recent work by a Keck School of Medicine of USC-led team has demonstrated that circadian clock proteins, which help coordinate changes in the body’s functions over the course of a day, may play a key role in glioblastoma growth and proliferation after current standard treatments. Read More

Hollings Cancer Center, Medical University of South Carolina Ashish Deshmukh, PhD, is the new co-leader of the cancer control program at MUSC Hollings Cancer Center and an associate professor in the Department of Public Health Sciences. Dr. Deshmukh focuses on human papillomavirus and the cancers it can cause. He joins co-leader Matthew Carpenter, PhD, who focuses on tobacco control and behavioral medicine. Read More

UCSF Helen Diller Family Comprehensive Cancer Center UCSFʻs Luke Gilbert, PhD, was among the recipients of Phase 1 funding for the Molecular Phenotypes of Null Alleles in Cells program, managed by the National Human Genome Research Institute. The program aims to systematically investigate the function of each gene through multiple phases that will each build upon the work of the previous one. Read More

University of Michigan Rogel Cancer Center Science fiction writer Arthur C. Clarke’s third law says, "Any sufficiently advanced technology is indistinguishable from magic." Indika Rajapakse, PhD, is a believer. The engineer and mathematician now finds himself a biologist. And he believes the beauty of blending these three disciplines is crucial to unraveling how cells work. Read More

Yale Cancer Center, Yale School of Medicine New research from Yale Cancer Center reveals a higher risk of cancer mortality in incarcerated adults, as well as among those diagnosed with cancer in the first year after release from prison. The study compared data using a statewide link between tumor registry and correctional system data for adults in Connecticut diagnosed with invasive cancer from 2005 through 2016. Read More

Huntsman Cancer Institute at the University of Utah Three Huntsman Cancer Institute investigators received grants from the V Foundation for cancer research. Doug Grossman, MD, PhD, earned a grant through the Translational Award Program. Conan Kinsey, MD, PhD, received his award through the Clinical Scholar Program, and Keren Hilgendorf, PhD, a member of the Cell Response and Regulation Program at Huntsman, also obtained funding. Read More

UAMS Winthrop P. Rockefeller Cancer Institute Sunny R. K. Singh, MD, has joined the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute as director of the UAMS Baptist Health Cancer Center. The satellite cancer center is jointly operated by the Rockefeller Cancer Institute and Baptist Health. Read More

Roswell Park Comprehensive Cancer Center After nearly three decades of service-focused work in the fields of education, government, education, and nursing, Ellen Grant, PhD, LCSW-R, is returning to health care, joining Roswell Park Comprehensive Cancer Center in the newly created role of executive director for corporate social responsibility and community education. Read More

The Tisch Cancer Institute at Mount Sinai Fred R. Hirsch, MD, PhD, is team leader on a grant award from Stand Up To Cancer to investigate therapeutic options for lung cancer characterized by KRAS mutations. The researchers will aim to identify therapeutic combinations that build on the impact of JZP-815, a novel pan-RAF inhibitor that has been shown to boost the effect of other therapeutic agents used to treat non-small cell lung cancer with KRAS mutations. Read More

On Monday, September 12, AACI Executive Director Jennifer W. Pegher attended an event at the John F. Kennedy Presidential Library and Museum in Boston, where President Joe Biden shared progress updates on the Cancer Moonshot 2.0. Held on the 60th anniversary of President Kennedy's famous Moonshot speech, the event also included President Biden's announcement of his intention to appoint Dr. Renee Wegrzyn as the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H). Rea…

AACI commends the National Cancer Institute (NCI) on the release of its Annual Plan & Budget Proposal for Fiscal Year (FY) 2024 and its request for $9.988 billion in funding – a significant increase over previous years. Priorities include increasing the R01 payline, expanding and modernizing cancer clinical trials, building on the success of the Cancer Moonshot and the 21st Century Cures Act, advancing health equity, and fostering a diverse cancer research workforce. Read More

UCSF Helen Diller Family Comprehensive Cancer Center First Lady Jill Biden, PhD, met with top UC San Francisco cancer leaders to hear about UCSF’s breast cancer research and progress on the National Cancer Moonshot. The visit highlighted the complexities of cancer, as well as UCSF advances in breast cancer research and programs that support breast cancer patients, survivors, and caregivers. Read More

Fred Hutchinson Cancer Center The Bezos family has committed $710.5 million over the next decade to support Fred Hutchinson Cancer Center's efforts to dramatically accelerate medical breakthroughs in cancer and infectious disease. This is the second recent transformational Fred Hutch donor commitment; a gift of $78 million from Stuart and Molly Sloan was announced in September. Thomas J. Lynch Jr., MD, is the center's president and director. Read More

Naoto T. Ueno, MD, PhD, has been named the next director of the University of Hawaiʻi (UH) Cancer Center, effective December 12. Dr. Ueno is currently the executive director of the Inflammatory Breast Cancer Research Program at The University of Texas MD Anderson Cancer Center, where he is also a tenured professor of medicine. He has spent 15 years in leadership roles and has nearly 30 years of experience in research and education, particularly in stem cell transplant, gene therapy, targeted th…

Cedars-Sinai Cancer The Convergent Science Virtual Cancer Center, a program designed to train the next generation of cancer researchers, held its first in-person workshop for its first class of scholars. The program, led by Cedars-Sinai Cancer and the University of Southern California, is funded by an inaugural grant from the Department of Defense. Dan Theodorescu, MD, PhD, is director of Cedars-Sinai Cancer. Read More

Yale Cancer Center, Yale School of Medicine Over the last decade, major professional societies have recommended that clinicians decrease the use of systemic anti-cancer therapies at the end-of-life stage. In a new study, researchers at Yale Cancer Center, in collaboration with researchers from Flatiron Health, Inc., revealed that despite these recommendations, aggressive cancer care at the end of life persists and there has been a substantial transition from the use of chemotherapy to im…

University of Michigan Rogel Cancer Center An international team of researchers led by the University of Michigan Rogel Cancer Center received a collaborative grant from the National Cancer Institute with a goal of bringing new insights into leiomyosarcoma, a rare form of cancer that seemingly originates in smooth muscle. Read More

Siteman Cancer Center John F. DiPersio, MD, PhD, director of the Division of Oncology at Washington University School of Medicine in St. Louis, is being recognized by the American Italian Cancer Foundation with the 2022 Prize for Scientific Excellence in Medicine. Read More

Vanderbilt-Ingram Cancer Center A Veterans Health Administration project that provided resources for lung cancer screening programs increased the number of veterans screened, according to a new study. The findings have already been used to advocate for a Department of Veterans Affairs National Lung Cancer Screening Program Office, which is now in place. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine The National Cancer Institute has awarded more than $10.3 million to continue translational lymphoma research at the Center for Cell and Gene Therapy at Baylor College of Medicine, Houston Methodist Hospital, and Texas Children’s Hospital. The grant is awarded through the NCI’s Specialized Programs of Research Excellence (SPORE) funding, which was established to promote collaborative, interdisciplinary translational c…

Simmons Comprehensive Cancer Center, UT Southwestern Medical Center An enzyme called Fic, whose biochemical role was discovered at UT Southwestern more than a dozen years ago, appears to play a crucial part in guiding the cellular response to stress, a new study suggests. The findings could eventually lead to new treatments for a variety of diseases. Read More

Indiana University Melvin and Bren Simon Comprehensive Cancer Center The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has named Michele Coté, PhD, director of the Susan G. Komen Tissue Bank, the world’s only healthy breast tissue bank. She succeeds Anna Maria Storniolo, MD, a pioneering clinical scientist who co-founded the tissue bank in 2007. Read More

University of Colorado Cancer Center As lead investigator or sub-investigator on numerous clinical trials at the University of Colorado Cancer Center Jessica McDermott, MD, has been instrumental in improving access to cancer clinical trials for patients from medically underserved communities. She will now bring her expertise in this area to her new role as deputy associate director for diversity and inclusion in clinical research. Read More

Winship Cancer Institute of Emory University The National Cancer Institute recently awarded more than $7.9 million for a new Radiation Oncology-Biology Integration Network (ROBIN) center at Winship Cancer Institute and the Cleveland Clinic. The ROBIN Genomic-TME-Temporal Dynamics Center aims to uncover the genetic and environmental factors, as well as the timing and interactions, that influence the effectiveness of radiation-based combination therapies. Read More

The University of Texas MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center and World Health Organization have announced a formal agreement to establish a new international collaboration concentrated on reducing the global burden of women’s cancers. Read More

The University of Kansas Cancer Center The University of Kansas Cancer Center is now a member of the National Cancer Institute’s Experimental Therapeutics Clinical Trials Network (ETCTN) as part of a consortium led by Yale Cancer Center. ETCTN membership will increase the number of early-stage clinical trials the cancer center can offer to people with cancer. Read More

Fred Hutchinson Cancer Center Ruth Etzioni, PhD, has received a seven-year Outstanding Investigator Award from the National Cancer Institute. The award, which comes with around $7.4 million in funding, will allow Dr. Etzioni and her team to build frameworks and tools to evaluate novel cancer diagnostics such as new nuclear imaging modalities and multi-cancer early detection tests. Read More

University of Michigan Rogel Cancer Center In Michigan, 40 percent of callers to the state’s Tobacco Quitline are menthol users. Now, a new partnership between the University of Michigan Rogel Cancer Center and the Quitline will develop and test strategies to help menthol users kick the habit. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Finding valuable therapeutic interventions for prostate cancer has long guided the research of the lab of Feng Yang, PhD, at Baylor College of Medicine. In a new study, Dr. Yang’s team took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy. Working with cells in the lab and animal models, they discovered an approach that suppresses the growth of thera…

Cedars-Sinai Cancer Yuan Yuan, MD, PhD, a breast medical oncologist and physician scientist who specializes in triple-negative breast cancer and breast cancer immunotherapy, has joined Cedars-Sinai Cancer as director of breast oncology. Dr. Yuan will also treat patients at Huntington Cancer Center, an affiliate of Cedars-Sinai Cancer. Read More

Sidney Kimmel Cancer Center at Jefferson Health Sidney Kimmel Cancer Center (SKCC) welcomes transdisciplinary population health researcher Terry Hyslop, PhD, as co-leader of the Cancer Risk and Control Program. She will also head the newly formed SKCC Center for Health Equity. Dr. Hyslop is returning to the cancer center from Duke Cancer Institute. Read More

The University of Texas MD Anderson Cancer Center The James P. Allison Institute at The University of Texas MD Anderson Cancer Center has announced the establishment of its internal advisory council to provide scientific input and to align the work of the institute with the broader MD Anderson research enterprise. Read More

The Tisch Cancer Institute at Mount Sinai Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast cancer cells regulate their own metastases, fuel dissemination from the original tumor site, and determine routes to invade distant organs such as the lungs. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Researchers from Johns Hopkins Medicine have discovered that the organization of different types of immune cells within pancreatic tumors is associated with how well patients with pancreatic cancer respond to treatment and how long they survive. The new findings could eventually lead to new ways of treating pancreatic cancer. Read More

Montefiore Einstein Comprehensive Cancer Center A clinical trial now kicking off at Montefiore Einstein Cancer Center will test whether scalp cooling can protect Black and Latina women with textured hair types from hair loss due to chemotherapy, known as chemotherapy-induced alopecia (CIA). The trial will also determine which women are at high risk for permanently losing their hair due to CIA. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center was recently awarded a grant for $6 million over the course of five years to develop a new Cancer Prevention-Interception Targeted Agent Discovery Program. The new National Cancer Institute (NCI) program was created to establish a pipeline for the discovery of new cancer-prevention agents. Read More

Fox Chase Cancer Center, Temple Health Jaye Gardiner, PhD, has received the Merton Bernfield Memorial Award, established to honor outstanding postdocs or graduate students, from the American Society for Cell Biology. Her research focuses on the tumor microenvironment and the growth of tumors in pancreatic ductal adenocarcinoma. Read More

Roswell Park Comprehensive Cancer Center Roswell Park Comprehensive Cancer Center is proud to break ground on a new Community Outreach and Engagement (COE) building. The project, which includes preservation of a home in Buffalo’s historic Fruit Belt neighborhood, will be the new home for the cancer center’s extensive COE team. Read More

Stanford Cancer Institute Stanford Health Care’s Blood and Marrow Transplantation & Cellular Therapy program performed its 500th Chimeric Antigen Receptor T-cell (CAR T) therapy infusion in September. The multi-disciplinary team—physicians, fellows, advanced practice providers, nurses, pharmacists, social workers, case management, clinic staff, and administrators—celebrated the milestone together. Read More

Stanford Cancer Institute Stanford Cancer Institute members Matthew Frank, MD, PhD, and David Miklos, MD, PhD, have received FDA breakthrough therapy designation on a trial using CAR22 to treat patients with relapsed/refractory large B-cell lymphoma that has progressed after prior CAR19 therapy. Read More

UMMC Cancer Center and Research Institute The University of Mississippi Medical Center (UMMC) welcomes Wade Christopher, MD, who will be part of the UMMC Cancer Center and Research Institute's interdisciplinary liver and bile duct cancer care team and the gastrointestinal cancer care team. He’ll also work with patients with sarcoma, thyroid, and melanoma cancers. Read More

AACI has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers, and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute A new national survey commissioned by The Ohio State University Comprehensive Cancer Center – The James found that most women are unaware of the unusual symptoms of a particularly aggressive and deadly form of the disease known as inflammatory breast cancer. Read More

Winship Cancer Institute of Emory University The combination of an immunotherapy, PD-1 blockade, and biologic therapy, IL-2 therapy, generate higher quality effector CD8+ T cells which resemble the highly functional effector CD8+ T cells seen after acute viral infection that help the immune system control or clear the virus. Read More

Laura and Isaac Perlmutter Cancer Center at NYU Langone A new study, led by researchers at NYU Grossman School of Medicine and NYU Langone Health’s Perlmutter Cancer Center, has generated data suggesting that a newly identified panel of autoantibodies, if found in patients’ blood before immunotherapy, has the potential to accurately predict whether cancer would recur for a patient and if they would experience autoimmune side effects because of the treatment itself. Read More

UK Markey Cancer Center UK Markey Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer. UK Markey is one of around 60 centers in the nation and the first in Kentucky to hold this designation. Read More

Huntsman Cancer Institute at the University of Utah Scientists have solved a long-standing mystery surrounding a cancer-promoting protein and how it causes tumor growth. The findings are an important step in the quest to make cancer drugs more effective since aggressive tumors often become adept at resisting drugs and other therapeutic agents. Read More

Simmons Comprehensive Cancer Center, UT Southwestern Medical Center Researchers at UT Southwestern and the University of Miami have discovered that a molecule—estrogen-related receptor gamma, or ESRRG—becomes hyperactive and promotes tumor cell survival in retinoblastoma. Blocking ESRRG, the team reported, kills retinoblastoma cells. Read More

The University of Arizona Cancer Center A team of University of Arizona researchers have developed a drug compound that appears to stop cancer cell growth in triple-negative breast cancer. The drug, which has not yet been tested in humans, has been shown to eliminate tumors in mice, with little to no effect on normal healthy cells, making it potentially nontoxic for patients. Read More

UK Markey Cancer Center A UK Markey Cancer Center researcher’s team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors. The new gold-derived compounds were toxic to cancer cells but well-tolerated by mice, giving them potential in the development of new cancer drugs. Read More

University of Colorado Cancer Center Jan Lowery, PhD, MPH, who started her career as a researcher at the University of Colorado Cancer Center, has returned as assistant director for dissemination and implementation for the Office of Community Outreach and Engagement. In her new role, Dr. Lowery will lead efforts to develop, conduct, and disseminate implementation-focused projects in cancer prevention, early detection, and survivorship. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The addition of four new oncologists—Sonia T. Orcutt, MD; Cesar Giancarlo Gentille Sanchez, MD; Santanu Samanta, MD; and Anusha Jillella, MD—will expand services and increase access for patients at UAMS Winthrop P. Rockefeller Cancer Institute and its growing network of clinics at Baptist Health locations. Read More

The AACI Physician Clinical Leadership Initiative (PCLI) will host "A Transdisciplinary 'Tweetorial' With Seasoned Colleagues" at 5:00 pm eastern time on Tuesday, November 15. The webinar will provide a moderated discussion with colleagues in medical, radiation, and surgical oncology about social media and how it can best be harnessed to promote individuals, teams, and the war on cancer. Read More

Laura and Isaac Perlmutter Cancer Center at NYU Langone NYU Langone Health has announced the appointment of physician and researcher Oren Cahlon, MD, as senior vice president and deputy chief clinical officer. Dr. Cahlon will also maintain a clinical practice within the Department of Radiation Oncology at Perlmutter Cancer Center. Read More

On Monday, October 24, AACI Executive Director Jennifer W. Pegher visited the White House for the announcement of the American Cancer Society’s launch of the National Breast Cancer Roundtable and the National Roundtable on Cervical Cancer. The following day, Pegher attended an event at Howard University that included a discussion between U.S. Department of Health and Human Services Secretary Xavier Becerra, JD, and ARPA-H Director Renee Wegrzyn, PhD. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute announces the appointment of two researchers as holders of endowed chairs at the University of Utah. Another colleague was awarded a fellowship, and two other distinguished endowed chairs have been renewed. Read More

UAMS Winthrop P. Rockefeller Cancer Institute Dina M. Jones, PhD, MPH, has received a grant to study disparities in smoking cessation among African American menthol cigarette smokers. The project seeks to understand why African American cigarette smokers—more than 85 percent of whom use menthol cigarettes—are less likely to quit smoking than white smokers and those who use non-menthol cigarettes. Read More

Fox Chase Cancer Center, Temple Health Robert Uzzo, MD, MBA, FACS, has been formally named president and CEO of Fox Chase Cancer Center following a period of interim leadership. In addition, Dr. Uzzo will assume the roles of executive vice president, cancer services, for Temple University Health System and senior associate dean, clinical cancer research at the Lewis Katz School of Medicine at Temple University. Read More

The University of Texas MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center has announced that Eyal Gottlieb, PhD, has been named the institution’s vice president for research. Since 2020, Dr. Gottlieb has served as director of the Rappaport Institute for Biomedical Research and vice dean of research for the Technion Faculty of Medicine. Read More

Duke Cancer Institute, Duke University Medical Center The Radiation Research Society has bestowed its highest honor—the Failla Memorial Lecture Award—on Michael B. Kastan, MD, PhD, executive director of Duke Cancer Institute. The 59th recipient of the annual award, Dr. Kastan reported a number of seminal discoveries demonstrating that the protein p53 is a critical mediator of how cells respond to DNA damage. Read More

Joseph A. Califano III, MD, has been named director of Moores Cancer Center at UC San Diego Health. He succeeds Scott Lippman, MD, who announced in November 2021 that he would be stepping down as director to lead the National Cancer Institute's PreCancer Genome Atlas. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The new Lung Nodule Program at The Ohio State University Comprehensive Cancer Center – The James combines the benefits of automated natural language processing tools with a subspecialized treatment team to create a system for flagging and methodically evaluating incidental lung nodule findings to capture subtle signs of lung cancer. Read More

Sidney Kimmel Cancer Center at Jefferson Health Jefferson Health’s Sidney Kimmel Cancer Center has launched the Geriatric Oncology Center of Excellence to address the needs of a growing patient population through multidisciplinary research and care delivery. The center identifies and removes barriers for older patients with cancer to optimize health outcomes and improve quality of life. Read More

AACI hosted its first Leadership Diversity and Development Initiative (LDDI) Workshop on November 8-9 in Chicago. Dr. Caryn Lerman, AACI president and director of the USC Norris Comprehensive Cancer Center, welcomed nearly 100 participants from 78 AACI cancer centers. The attendees represented a diverse group of cancer center leaders as well as emerging leaders nominated by their centers. LDDI is Dr. Lerman’s AACI presidential initiative. Read More

Stanford Cancer Institute Crystal Mackall, MD, and lead author Katie Freitas, a Stanford Immunology PhD candidate and Mackall lab member, have published an article demonstrating that the Mediator kinase module is a primary regulator of T cell effector programming. Read More

Duke Cancer Institute, Duke University Medical Center Duke University Provost Sally Kornbluth, PhD, has been appointed president of the Massachusetts Institute of Technology (MIT), beginning in January 2023. Dr. Kornbluth has been a member of Duke Cancer Institute since 1990. Her lab, which studied the regulation of complex cellular processes, closed when she assumed the role of provost in 2014. Read More

Moffitt Cancer Center Moffitt Cancer Center’s efforts to increase minority accrual to cancer treatment trials got a boost from the National Cancer Institute’s Connecting Underrepresented Populations to Clinical Trials U01 Grants Program. The five-year, $3.7 million grant will help the cancer center develop new digital tools and community outreach strategies to reach Black and Hispanic cancer patients and physicians in the Tampa Bay community. Read More

Montefiore Einstein Comprehensive Cancer Center Ulrich Steidl, MD, PhD, has been named the chair of the department of cell biology at Albert Einstein College of Medicine. Dr. Steidl assumes his new position as Arthur Skoultchi, PhD, who has led the department for 24 years, steps down from departmental leadership. Dr. Steidl is currently deputy director of Montefiore Einstein Cancer Center and co-director of its Blood Cancer Institute. Read More

Sylvester Comprehensive Cancer Center, University of Miami Antonio Iavarone, MD, has made a decades-long commitment to finding better treatments for glioblastoma and other aggressive brain tumors. As the new deputy director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, he will have opportunities to do even more. Read More

Vanderbilt-Ingram Cancer Center Cribriform prostate cancer is an aggressive subtype of the disease characterized by its histology, but little is known about its molecular pathways. Research from Vanderbilt-Ingram Cancer Center has revealed new information about these pathways, including potential therapies. Read More

University of Michigan Rogel Cancer Center A dietary change could be a key to enhancing colon cancer treatment, a study from the University of Michigan Rogel Cancer Center finds. One of the most important nutrient sensing molecules in a cell is called mTORC1. While mTORC1 is known to be hyperactive in colon cancer, the key question is whether colon tumors hijack nutrient sensing pathways to fire up the master regulator. Read More

University of Michigan Rogel Cancer Center Researchers at the University of Michigan Rogel Cancer Center have identified a novel treatment approach to an aggressive type of pediatric brain cancer, using therapies already approved to treat cancer. Read More

Winship Cancer Institute of Emory University A targeted therapy for children with high-risk Hodgkin lymphoma was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children’s Oncology Group and led by pediatric oncologists at Winship Cancer Institute of Emory University, Children’s Healthcare of Atlanta and Roswell Park Comprehensive Cancer Center. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center researchers to successfully detect lung cancer in a 2021 study has now detected more than 80 percent of liver cancers in a new study of 724 people. Read More

Moffitt Cancer Center Jarett Rieger, Esq., MBA, has been named Moffitt Cancer Center’s new vice president and chief innovation officer. He will continue to oversee Moffitt’s Office of Innovation and Industry Alliances, which is focused on commercializing intellectual property. Rieger joined Moffitt in 2004 and has served as the manager, director, and senior director of this office before being promoted to the new role. Read More

The University of Kansas Cancer Center The University of Kansas Cancer Center has announced the appointment of Megha Ramaswamy, PhD, MPH, as its inaugural associate director for cancer workforce equity. In this newly created role, Dr. Ramaswamy will be responsible for developing a plan to diversify the cancer research and care workforce. Read More

Winship Cancer Institute of Emory University A $1.34 million Science Education Partnership Award from the National Institutes of Health will help Winship Cancer Institute scientists investigate whether problem-based learning, directly applied to case studies relevant to communities in Georgia, will more effectively help to increase diversity in the biomedical research workforce and reduce health disparities. Read More

On November 15, 2022, AACI's Physician Clinical Leadership Initiative (PCLI) hosted a moderated discussion with colleagues in medical, radiation, and surgical oncology about social media and how it can best be harnessed to promote individuals, teams, and the war on cancer. They will have an honest discussion about mistakes made and how to learn from them and will share a practical Dos and Don’ts of Twitter. The webinar was presented by Julie Ann Sosa, MD, MA, FACS, MAMSE, FFSO, Professor of Sur…

Sylvester Comprehensive Cancer Center, University of Miami Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review that clarifies current treatment approaches for myelodysplastic syndromes. Read More